Indigenous community-guided chemical genomic insight into synergy of rapamycin with nerolidol derived from a leaf extract of kānuka (Kunzea robusta) in Tairāwhiti, Aotearoa New Zealand
Maximizing efficacy and minimizing toxicity are essential in drug discovery. Utilizing a natural product combinatorial approach can offer a promising strategy to preserve bioactivity while reducing the dosage of potentially toxic drugs in patient treatment. Kānuka (Kunzea robusta) is a well-known en...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Phytomedicine Plus |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667031325000442 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850191213994442752 |
|---|---|
| author | Storm Blockley-Powell Sarah Andreassend Bella Paenga Damian Skinner Nikki Harcourt Manu Caddie Teresa Moreno Stephen Tallon Robert A. Keyzers Andrew B. Munkacsi |
| author_facet | Storm Blockley-Powell Sarah Andreassend Bella Paenga Damian Skinner Nikki Harcourt Manu Caddie Teresa Moreno Stephen Tallon Robert A. Keyzers Andrew B. Munkacsi |
| author_sort | Storm Blockley-Powell |
| collection | DOAJ |
| description | Maximizing efficacy and minimizing toxicity are essential in drug discovery. Utilizing a natural product combinatorial approach can offer a promising strategy to preserve bioactivity while reducing the dosage of potentially toxic drugs in patient treatment. Kānuka (Kunzea robusta) is a well-known endemic plant of Aotearoa New Zealand that has therapeutic value with traditional knowledge and preliminary laboratory studies indicating antimicrobial bioactivities, yet combinatorial bioactivity studies of this plant are non-existent. Via a research collaboration led by an indigenous Māori social enterprise that ensured indigenous landowners contributed biological material and knowledge with free, prior and informed consent at each stage of the study, we show that a steam extract of kānuka leaves has synergistic activity with the well-known immunosuppressive agent, rapamycin, resulting in amplified bioactivity in the model organism Saccharomyces cerevisiae. Network analysis of a genome-wide gene deletion screen suggested the extract increased the bioavailability of rapamycin. Subsequent fluorescent microscopy analyses revealed the importance of endocytic and oxidative stress pathways. Bioassay-guided metabolomic analyses elucidated the main component of the steam extract, α-pinene, to not be responsible for the synergistic bioactivity, rather, highlighting nerolidol as a strong synergistic candidate. Given rapamycin is an advanced compound in many clinical studies involving anti-cancer, anti-ageing, and anti-microbial activities, albeit associated with several toxic side-effects, this study provides mechanistic insight into this previously unknown bioactivity of kānuka leaves and illustrates how a lower, and safer, concentration of rapamycin could be potentially used in these diverse clinical settings. |
| format | Article |
| id | doaj-art-e3526503ecd94916a3db660c90da5f8c |
| institution | OA Journals |
| issn | 2667-0313 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Phytomedicine Plus |
| spelling | doaj-art-e3526503ecd94916a3db660c90da5f8c2025-08-20T02:14:59ZengElsevierPhytomedicine Plus2667-03132025-05-015210077110.1016/j.phyplu.2025.100771Indigenous community-guided chemical genomic insight into synergy of rapamycin with nerolidol derived from a leaf extract of kānuka (Kunzea robusta) in Tairāwhiti, Aotearoa New ZealandStorm Blockley-Powell0Sarah Andreassend1Bella Paenga2Damian Skinner3Nikki Harcourt4Manu Caddie5Teresa Moreno6Stephen Tallon7Robert A. Keyzers8Andrew B. Munkacsi9School of Biological Sciences, Victoria University of Wellington, Wellington 6012, Aotearoa New ZealandSchool of Biological Sciences, Victoria University of Wellington, Wellington 6012, Aotearoa New ZealandHikurangi Bioactives Limited Partnership, Ruatōria 4081, Aotearoa New ZealandHikurangi Bioactives Limited Partnership, Ruatōria 4081, Aotearoa New ZealandHikurangi Bioactives Limited Partnership, Ruatōria 4081, Aotearoa New Zealand; Manaaki Whenua – Landcare Research, Hamilton 3216, Aotearoa New ZealandHikurangi Bioactives Limited Partnership, Ruatōria 4081, Aotearoa New ZealandCallaghan Innovation, Lower Hutt 5010, Aotearoa New ZealandCallaghan Innovation, Lower Hutt 5010, Aotearoa New ZealandSchool of Chemical and Physical Sciences, Victoria University of Wellington, Wellington 6012, Aotearoa New Zealand; Centre for Biodiscovery, Victoria University of Wellington, Wellington 6012, Aotearoa New ZealandSchool of Biological Sciences, Victoria University of Wellington, Wellington 6012, Aotearoa New Zealand; Centre for Biodiscovery, Victoria University of Wellington, Wellington 6012, Aotearoa New Zealand; Corresponding author at: School of Biological Sciences, Victoria University of Wellington, Wellington 6012, Aotearoa New Zealand.Maximizing efficacy and minimizing toxicity are essential in drug discovery. Utilizing a natural product combinatorial approach can offer a promising strategy to preserve bioactivity while reducing the dosage of potentially toxic drugs in patient treatment. Kānuka (Kunzea robusta) is a well-known endemic plant of Aotearoa New Zealand that has therapeutic value with traditional knowledge and preliminary laboratory studies indicating antimicrobial bioactivities, yet combinatorial bioactivity studies of this plant are non-existent. Via a research collaboration led by an indigenous Māori social enterprise that ensured indigenous landowners contributed biological material and knowledge with free, prior and informed consent at each stage of the study, we show that a steam extract of kānuka leaves has synergistic activity with the well-known immunosuppressive agent, rapamycin, resulting in amplified bioactivity in the model organism Saccharomyces cerevisiae. Network analysis of a genome-wide gene deletion screen suggested the extract increased the bioavailability of rapamycin. Subsequent fluorescent microscopy analyses revealed the importance of endocytic and oxidative stress pathways. Bioassay-guided metabolomic analyses elucidated the main component of the steam extract, α-pinene, to not be responsible for the synergistic bioactivity, rather, highlighting nerolidol as a strong synergistic candidate. Given rapamycin is an advanced compound in many clinical studies involving anti-cancer, anti-ageing, and anti-microbial activities, albeit associated with several toxic side-effects, this study provides mechanistic insight into this previously unknown bioactivity of kānuka leaves and illustrates how a lower, and safer, concentration of rapamycin could be potentially used in these diverse clinical settings.http://www.sciencedirect.com/science/article/pii/S2667031325000442Kunzea robustaKānukaNatural productRapamycinSynergyChemical genetics |
| spellingShingle | Storm Blockley-Powell Sarah Andreassend Bella Paenga Damian Skinner Nikki Harcourt Manu Caddie Teresa Moreno Stephen Tallon Robert A. Keyzers Andrew B. Munkacsi Indigenous community-guided chemical genomic insight into synergy of rapamycin with nerolidol derived from a leaf extract of kānuka (Kunzea robusta) in Tairāwhiti, Aotearoa New Zealand Phytomedicine Plus Kunzea robusta Kānuka Natural product Rapamycin Synergy Chemical genetics |
| title | Indigenous community-guided chemical genomic insight into synergy of rapamycin with nerolidol derived from a leaf extract of kānuka (Kunzea robusta) in Tairāwhiti, Aotearoa New Zealand |
| title_full | Indigenous community-guided chemical genomic insight into synergy of rapamycin with nerolidol derived from a leaf extract of kānuka (Kunzea robusta) in Tairāwhiti, Aotearoa New Zealand |
| title_fullStr | Indigenous community-guided chemical genomic insight into synergy of rapamycin with nerolidol derived from a leaf extract of kānuka (Kunzea robusta) in Tairāwhiti, Aotearoa New Zealand |
| title_full_unstemmed | Indigenous community-guided chemical genomic insight into synergy of rapamycin with nerolidol derived from a leaf extract of kānuka (Kunzea robusta) in Tairāwhiti, Aotearoa New Zealand |
| title_short | Indigenous community-guided chemical genomic insight into synergy of rapamycin with nerolidol derived from a leaf extract of kānuka (Kunzea robusta) in Tairāwhiti, Aotearoa New Zealand |
| title_sort | indigenous community guided chemical genomic insight into synergy of rapamycin with nerolidol derived from a leaf extract of kanuka kunzea robusta in tairawhiti aotearoa new zealand |
| topic | Kunzea robusta Kānuka Natural product Rapamycin Synergy Chemical genetics |
| url | http://www.sciencedirect.com/science/article/pii/S2667031325000442 |
| work_keys_str_mv | AT stormblockleypowell indigenouscommunityguidedchemicalgenomicinsightintosynergyofrapamycinwithnerolidolderivedfromaleafextractofkanukakunzearobustaintairawhitiaotearoanewzealand AT sarahandreassend indigenouscommunityguidedchemicalgenomicinsightintosynergyofrapamycinwithnerolidolderivedfromaleafextractofkanukakunzearobustaintairawhitiaotearoanewzealand AT bellapaenga indigenouscommunityguidedchemicalgenomicinsightintosynergyofrapamycinwithnerolidolderivedfromaleafextractofkanukakunzearobustaintairawhitiaotearoanewzealand AT damianskinner indigenouscommunityguidedchemicalgenomicinsightintosynergyofrapamycinwithnerolidolderivedfromaleafextractofkanukakunzearobustaintairawhitiaotearoanewzealand AT nikkiharcourt indigenouscommunityguidedchemicalgenomicinsightintosynergyofrapamycinwithnerolidolderivedfromaleafextractofkanukakunzearobustaintairawhitiaotearoanewzealand AT manucaddie indigenouscommunityguidedchemicalgenomicinsightintosynergyofrapamycinwithnerolidolderivedfromaleafextractofkanukakunzearobustaintairawhitiaotearoanewzealand AT teresamoreno indigenouscommunityguidedchemicalgenomicinsightintosynergyofrapamycinwithnerolidolderivedfromaleafextractofkanukakunzearobustaintairawhitiaotearoanewzealand AT stephentallon indigenouscommunityguidedchemicalgenomicinsightintosynergyofrapamycinwithnerolidolderivedfromaleafextractofkanukakunzearobustaintairawhitiaotearoanewzealand AT robertakeyzers indigenouscommunityguidedchemicalgenomicinsightintosynergyofrapamycinwithnerolidolderivedfromaleafextractofkanukakunzearobustaintairawhitiaotearoanewzealand AT andrewbmunkacsi indigenouscommunityguidedchemicalgenomicinsightintosynergyofrapamycinwithnerolidolderivedfromaleafextractofkanukakunzearobustaintairawhitiaotearoanewzealand |